Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose thalidomide for minor recurrent aphthous ulcer
ChiCTR-IPR-16009759Phase 4Not yet recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of thalidomide in aphthosis (RAS) (3 arms), sponsored by Shanghai Ninth People's Hospital. Planned start Dec 2016; status: not yet recruiting.
02
Drugs
thalidomide
03
Conditions
aphthosis (RAS)
Beyond the preview
Go deeper on ChiCTR-IPR-16009759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009759.